Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
about 220 employees (http://www.icm.uu.se ). The PhD position is available in Jens Carlsson’s group in the computational biology and bioinformatics programme. Jens Carlsson’s research focuses on using
-
research programs with about 220 employees (http://www.icm.uu.se ). The PhD position is available in Jens Carlsson’s group in the computational biology and bioinformatics programme. Jens Carlsson’s research
-
your character. If you can tick these boxes, you should continue reading. The overall aim of this PhD research program is to improve the use of computed tomography (CT) images for detailed and
-
study plan. For a doctoral degree, the equivalent of four years of full-time doctoral education is required. One Ph.D. position is available in cancer precision medicine using advanced machine learning
-
causal relations between genetic alterations and disease phenotypes. In this PhD you will address this by a deep learning model of drug responses in cancer. The PhD position focuses on predicting cell type
-
the EU Research Framework Programme? Not funded by an EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description Admission to Doctoral (PhD) Studies in
-
an individual study plan. For a doctoral degree, the equivalent of four years of full-time doctoral education is required. One Ph.D. position is available in bioinformatics with a focus on large-scale data
-
phenotypes. In this PhD you will address this by a deep learning model of drug responses in cancer. The PhD position focuses on predicting cell type-specific drug responses, identifying transcriptional
-
-throughput drug screening and single-cell sequencing. The position will be co-supervised by Professor Jens Lagergren at the Division of Computational Science and Technology, Royal Institute of Technology and
-
phenotypes. In this PhD you will address this by a deep learning model of drug responses in cancer. The PhD position focuses on predicting cell type-specific drug responses, identifying transcriptional